Inspecs Group plc

LSE:SPEC UK Medical Instruments & Supplies
Market Cap
$1.03 Million
GBX8.44 Billion GBX
Market Cap Rank
#45191 Global
#856 in UK
Share Price
GBX83.00
Change (1 day)
+0.00%
52-Week Range
GBX38.50 - GBX86.00
All Time High
GBX405.33
About

INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia. It operates through Frames and Optics; Manufacturing; and Lenses segments. The company offers its products under the retail brands, such as Barbour, Barbour International, BUFFALO David Bitton, CAT,… Read more

Inspecs Group plc (SPEC) - Net Assets

Latest net assets as of June 2025: GBX89.10 Million GBX

Based on the latest financial reports, Inspecs Group plc (SPEC) has net assets worth GBX89.10 Million GBX as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX203.83 Million) and total liabilities (GBX114.73 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX89.10 Million
% of Total Assets 43.71%
Annual Growth Rate 60.61%
5-Year Change -32.32%
10-Year Change N/A
Growth Volatility 267.24

Inspecs Group plc - Net Assets Trend (2016–2024)

This chart illustrates how Inspecs Group plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Inspecs Group plc (2016–2024)

The table below shows the annual net assets of Inspecs Group plc from 2016 to 2024.

Year Net Assets Change
2024-12-31 GBX98.69 Million -4.67%
2023-12-31 GBX103.52 Million -20.43%
2022-12-31 GBX130.09 Million -10.42%
2021-12-31 GBX145.22 Million -0.41%
2020-12-31 GBX145.82 Million +365.16%
2019-12-31 GBX31.35 Million +38.01%
2018-12-31 GBX22.71 Million +16.19%
2017-12-31 GBX19.55 Million +777.26%
2016-12-31 GBX2.23 Million --

Equity Component Analysis

This analysis shows how different components contribute to Inspecs Group plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 477869900.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock GBX1.02 Million 1.03%
Other Components GBX103.26 Million 104.63%
Total Equity GBX98.69 Million 100.00%

Inspecs Group plc Competitors by Market Cap

The table below lists competitors of Inspecs Group plc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Inspecs Group plc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 103,517,000 to 98,686,000, a change of -4,831,000 (-4.7%).
  • Net loss of 4,608,000 reduced equity.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income GBX-4.61 Million -4.67%
Other Changes GBX-223.00K -0.23%
Total Change GBX- -4.67%

Book Value vs Market Value Analysis

This analysis compares Inspecs Group plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 85.51x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 2634.95x to 85.51x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 GBX0.03 GBX83.00 x
2017-12-31 GBX0.28 GBX83.00 x
2018-12-31 GBX0.32 GBX83.00 x
2019-12-31 GBX0.44 GBX83.00 x
2020-12-31 GBX2.11 GBX83.00 x
2021-12-31 GBX1.37 GBX83.00 x
2022-12-31 GBX1.28 GBX83.00 x
2023-12-31 GBX1.02 GBX83.00 x
2024-12-31 GBX0.97 GBX83.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Inspecs Group plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -4.67%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -2.32%
  • • Asset Turnover: 0.90x
  • • Equity Multiplier: 2.23x
  • Recent ROE (-4.67%) is below the historical average (3.12%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 31.80% 3.21% 1.54x 6.43x GBX485.82K
2017 -17.09% -6.79% 0.70x 3.57x GBX-5.30 Million
2018 15.40% 6.11% 0.83x 3.05x GBX1.23 Million
2019 15.67% 8.02% 0.86x 2.28x GBX1.78 Million
2020 -4.49% -13.79% 0.15x 2.13x GBX-21.12 Million
2021 -2.77% -2.21% 0.56x 2.25x GBX-18.55 Million
2022 -4.86% -3.14% 0.69x 2.25x GBX-19.33 Million
2023 -0.96% -0.49% 0.92x 2.14x GBX-11.35 Million
2024 -4.67% -2.32% 0.90x 2.23x GBX-14.48 Million

Industry Comparison

This section compares Inspecs Group plc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $62,632,000
  • Average return on equity (ROE) among peers: 4.99%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Inspecs Group plc (SPEC) GBX89.10 Million 31.80% 1.29x $8.66K
Advanced Medical Solutions Group plc (AMS) $152.44 Million 13.21% 0.11x $57.66K
Cambridge Nutritional Sciences plc (CNSL) $23.38 Million -9.00% 0.26x $579.03
Tristel (TSTL) $12.08 Million 10.75% 0.25x $22.16K